Literature DB >> 9416624

HIV-1 Nef protein: purification, crystallizations, and preliminary X-ray diffraction studies.

P Franken1, S Arold, A Padilla, M Bodeus, F Hoh, M P Strub, M Boyer, M Jullien, R Benarous, C Dumas.   

Abstract

Human immunodeficiency virus Nef protein accelerates virulent progression of AIDS by its interaction with specific cellular proteins involved in cellular activation and signal transduction. Here we report the purification and crystallization of the conserved core of HIV-1LAI Nef protein in the unliganded form and in complex with the wild-type SH3 domain of the P59fyn protein-tyrosine kinase. One-dimensional NMR experiments show that full-length protein and truncated fragment corresponding to the product of HIV-1 protease cleavage have a well-folded compact tertiary structure. The ligand-free HIV-1 Nefcore protein forms cubic crystals belonging to space group P23 with unit cell dimensions of a = b = c = 86.4 A. The Nef-Fyn SH3 cocrystals belong to the space group P6(1)22 or its enantiomorph, P6(5)22, with unit cell dimensions of a = b = 108.2 A and c = 223.7 A. Both crystal forms diffract to a resolution limit of 3.0 A resolution using synchrotron radiation, and are thus suitable for X-ray structure determination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416624      PMCID: PMC2143629          DOI: 10.1002/pro.5560061227

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  11 in total

1.  Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.

Authors:  C H Lee; K Saksela; U A Mirza; B T Chait; J Kuriyan
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

2.  Refined solution structure and backbone dynamics of HIV-1 Nef.

Authors:  S Grzesiek; A Bax; J S Hu; J Kaufman; I Palmer; S J Stahl; N Tjandra; P T Wingfield
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

3.  Use of dynamic light scattering to assess crystallizability of macromolecules and macromolecular assemblies.

Authors:  A R Ferré-D'Amaré; S K Burley
Journal:  Structure       Date:  1994-05-15       Impact factor: 5.006

4.  Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division.

Authors:  S Roche; S Fumagalli; S A Courtneidge
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

5.  Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1.

Authors:  J Freund; R Kellner; T Houthaeve; H R Kalbitzer
Journal:  Eur J Biochem       Date:  1994-04-15

6.  Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects.

Authors:  Y Collette; H Dutartre; A Benziane; R Benarous; M Harris; D Olive
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

7.  Directed evolution of biosynthetic pathways. Recruitment of cysteine thioethers for constructing the cell wall of Escherichia coli.

Authors:  C Richaud; D Mengin-Lecreulx; S Pochet; E J Johnson; G N Cohen; P Marlière
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

8.  Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic.

Authors:  S Benichou; M Bomsel; M Bodéus; H Durand; M Douté; F Letourneur; J Camonis; R Benarous
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

9.  A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.

Authors:  C H Lee; B Leung; M A Lemmon; J Zheng; D Cowburn; J Kuriyan; K Saksela
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

10.  Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.

Authors:  K Saksela; G Cheng; D Baltimore
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  8 in total

1.  Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.

Authors:  Martha J Lewis; Patricia Lee; Hwee L Ng; Otto O Yang
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

2.  Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.

Authors:  S Arold; F Hoh; S Domergue; C Birck; M A Delsuc; M Jullien; C Dumas
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

Review 3.  Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.

Authors:  Jeremiah F Roeth; Kathleen L Collins
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

4.  Application of a Novel CL7/Im7 Affinity System in Purification of Complex and Pharmaceutical Proteins.

Authors:  Louise T Chow; Dmitry G Vassylyev
Journal:  Methods Mol Biol       Date:  2022

5.  Pseudo-merohedral twinning and noncrystallographic symmetry in orthorhombic crystals of SIVmac239 Nef core domain bound to different-length TCRzeta fragments.

Authors:  Walter M Kim; Alexander B Sigalov; Lawrence J Stern
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

6.  Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.

Authors:  Ruth Serra-Moreno; Kerstin Zimmermann; Lawrence J Stern; David T Evans
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

7.  HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure.

Authors:  Martha J Lewis; Patricia Frohnen; F Javier Ibarrondo; Diane Reed; Varun Iyer; Hwee L Ng; Julie Elliott; Otto O Yang; Peter Anton
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 8.  Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Authors:  Philip Mwimanzi; Tristan J Markle; Takamasa Ueno; Mark A Brockman
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.